Ronny Johnson, MD
Vascular Surgery · Huntsville, ALNPI 1922047018
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Boston Scientific at 47.8% of the total. Reporting peaked in 2019 at $7,064 and has fallen 97.6% since, to $171 in 2023.
Across 104 payments — averaging $87.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Acell, Inc.$1K
- Silk Road Medical, Inc.$1K
- Musculoskeletal Transplant Foundation Inc.$788
- Medtronic$626
- Endologix LLC$612
- plus $668 from 11 others
What the payments were for
- Consulting fees$3,00033%
- Travel & lodging$2,30725%
- Food & beverage$3,75141%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 10 | $4,330 |
| Acell, Inc. | 7 | $1,026 |
| Silk Road Medical, Inc. | 7 | $1,008 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $788 |
| Medtronic(2 entities) | 34 | $626 |
| Endologix LLC | 3 | $612 |
| Cook Medical LLC | 27 | $359 |
| Lemaitre Vascular, Inc. | 1 | $91 |
| Bard Peripheral Vascular, Inc. | 4 | $62 |
| Novo Nordisk | 2 | $35 |
| Organogenesis Inc. | 1 | $29 |
| Abbott | 1 | $24 |
| Antares Pharma, Inc. | 1 | $17 |
| W. L. Gore & Associates, Inc. | 1 | $14 |
| Artivion, Inc. | 1 | $13 |
| EKOS Corporation | 1 | $12 |
| Smith+Nephew | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,058 in reported general payments places this provider in the 65th percentile of 61 vascular surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 11 | $13,100 |
| Tramadol Hcl | 12 | $87 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Huntsville
- Andrew KnottHuntsville$76K
- Marco CioppiHuntsville$21K
- Mell WelbornHuntsville$14K
- Benjamin ShepherdHuntsville$13K
- Tracy LoweryHuntsville$209
- Rick RobertsHuntsville$131
- Albert PacificoBirmingham$5.1M
- Brian SellersMontgomery$71K
- Peter PonsFlorence$54K
- Benjamin PearceBirmingham$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.